Naturally-occurring TGR5 agonists modulating glucagon-like peptide-1 biosynthesis and secretion.

作者: Laila Jafri , Samreen Saleem , Danielle Calderwood , Anna Gillespie , Bushra Mirza

DOI: 10.1016/J.PEPTIDES.2016.01.015

关键词:

摘要: Selective GLP-1 secretagogues represent a novel potential therapy for type 2 diabetes mellitus. This study examined the secretory activity of ethnomedicinal plant, Fagonia cretica, which is postulated to possess anti-diabetic activity. After extraction and fractionation extracts purified compounds were tested GIP in pGIP/neo STC-1 cells. Intracellular levels incretin hormones their gene expression also determined. Crude F. cretica stimulated both secretion, increased cellular hormone content, upregulated proglucagon, prohormone convertase. However, ethyl acetate partitioning significantly enriched this fraction underwent bioactivity-guided fractionation. Three isolated potent selective secretagogues: quinovic acid (QA) two QA derivatives, QA-3β-O-β-D-glycopyranoside QA-3β-O-β-D-glucopyranosyl-(28→1)-β-D-glucopyranosyl ester. All activated TGR5 receptor intracellular expression. derivatives more than QA. first time that its naturally-occurring have been shown activate stimulate secretion. These data provide plausible mechanism use may assist ongoing development agonists.

参考文章(37)
HE Parker, K Wallis, CW le Roux, KY Wong, F Reimann, FM Gribble, Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. British Journal of Pharmacology. ,vol. 165, pp. 414- 423 ,(2012) , 10.1111/J.1476-5381.2011.01561.X
Muhammad Ibrar, Abdur Rauf, Taibi Ben Hadda, Mohammad S Mubarak, Seema Patel, None, Quantitative ethnobotanical survey of medicinal flora thriving in Malakand Pass Hills, Khyber Pakhtunkhwa, Pakistan Journal of Ethnopharmacology. ,vol. 169, pp. 335- 346 ,(2015) , 10.1016/J.JEP.2015.04.052
S. Javaria Gilani, Rizwana Aleem Qureshi, S. Aneel Gilani, Indigenous Uses of Some Important Ethnomedicinal Herbs of Ayubia National Park, Abbottabad, Pakistan Ethnobotanical Leaflets. ,vol. 2006, pp. 32- ,(2006)
Peter R Flatt, Clifford J Bailey, Brian D Green, Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes Frontiers in Bioscience. ,vol. Volume, pp. 3648- 3660 ,(2008) , 10.2741/2956
Kelly L Johnston, Michael N Clifford, Linda M Morgan, Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine The American Journal of Clinical Nutrition. ,vol. 78, pp. 728- 733 ,(2003) , 10.1093/AJCN/78.4.728
Takaharu Maruyama, Yasuhisa Miyamoto, Takao Nakamura, Yoshitaka Tamai, Hiromasa Okada, Eiji Sugiyama, Tatsuji Nakamura, Hiraku Itadani, Kenichi Tanaka, Identification of membrane-type receptor for bile acids (M-BAR). Biochemical and Biophysical Research Communications. ,vol. 298, pp. 714- 719 ,(2002) , 10.1016/S0006-291X(02)02550-0
Karen A. Evans, Brian W. Budzik, Sean A. Ross, David D. Wisnoski, Jian Jin, Ralph A. Rivero, Mythily Vimal, George R. Szewczyk, Channa Jayawickreme, David L. Moncol, Thomas J. Rimele, Susan L. Armour, Susan P. Weaver, Robert J. Griffin, Sarva M. Tadepalli, Michael R. Jeune, Todd W. Shearer, Zibin B. Chen, Lihong Chen, Donald L. Anderson, J. David Becherer, Maite De Los Frailes, Francisco Javier Colilla, Discovery of 3-Aryl-4-isoxazolecarboxamides as TGR5 Receptor Agonists Journal of Medicinal Chemistry. ,vol. 52, pp. 7962- 7965 ,(2009) , 10.1021/JM901434T
Julie A. Lovshin, Daniel J. Drucker, Incretin-based therapies for type 2 diabetes mellitus. Nature Reviews Endocrinology. ,vol. 5, pp. 262- 269 ,(2009) , 10.1038/NRENDO.2009.48
Brian D Green, Peter R Flatt, Clifford J Bailey, Inhibition of dipeptidyl peptidase IV activity as a therapy of Type 2 diabetes Expert Opinion on Emerging Drugs. ,vol. 11, pp. 525- 539 ,(2006) , 10.1517/14728214.11.3.525